Compare Aspen Aerogels Inc (ASPN) vs Tesla, Inc. (TSLA) Price & Performance

ASPN trades at $5.16, down 1.53% on the day, with a bearish technical signal despite oversold RSI readings. The company reported a Q1 2026 loss of $0.28 per share, missing estimates, but revenue beat expectations. Recent news includes a 2025 Supplier of the Year award from General Motors and the staged restart of its East Providence facility. Financials show significant net losses but improving cash flow trends into 2026.

Outlook remains challenging with persistent losses and negative margins, though analyst consensus is strongly bullish (83% buy ratings). Key risks include execution on facility restarts and EV demand volatility. The stock offers high-risk growth potential if operational improvements and electrification trends accelerate profitability.

Tesla (TSLA) trades at $401.17, down 1.61% on the day, with technical indicators showing a neutral to bullish bias amid mixed earnings performance. The company reported revenue of $94.83B in 2025, but net income fell to $3.79B, reflecting margin pressures. Recent news highlights regulatory approval for self-driving software in Europe and a strategic pivot toward AI and robotics, though near-term delivery misses and competition remain headwinds.

Tesla's outlook balances innovation potential with execution risks. The stock trades at a premium valuation (P/E 374.09), requiring robust growth in autonomous driving and energy segments to justify current levels. Key risks include competitive intensity, macroeconomic sensitivity, and reliance on future technology adoption. Analyst consensus is mixed, with a $436.41 price target suggesting moderate upside if execution improves.